<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">32112393</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>06</Month>
        <Day>04</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>06</Month>
        <Day>04</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1399-0004</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>97</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Clinical genetics</Title>
          <ISOAbbreviation>Clin Genet</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A GLI3 variant leading to polydactyly in heterozygotes and Pallister-Hall-like syndrome in a homozygote.</ArticleTitle>
        <Pagination>
          <StartPage>915</StartPage>
          <EndPage>919</EndPage>
          <MedlinePgn>915-919</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/cge.13730</ELocationID>
        <Abstract>
          <AbstractText>Variants in transcriptional activator Gli Kruppel Family Member 3 (GLI3) have been reported to be associated with several phenotypes including Greig cephalopolysyndactyly syndrome (MIM #175700), Pallister-Hall syndrome (PHS) (MIM #146510), postaxial polydactyly types A1 (PAPA1) and B (PAPB) (MIM #174200), and preaxial polydactyly type 4 (MIM #174700). All these disorders follow an autosomal dominant pattern of inheritance. Hypothalamic hamartomas (MIM 241800) is associated with somatic variants in GLI3. We report a related couple with parents having PAPA1 and PAPB, who had a fetus with a phenotype most compatible with PHS. Molecular analyses demonstrated homozygosity for a pathogenic GLI3 variant (c.1927C &gt; T; p. Arg643*) in the fetus and heterozygosity in the parents. The genetic analysis in this family demonstrates that heterozygosity and homozygosity for the same GLI3 variant can cause a different phenotype. Furthermore, the occurrence of Pallister-Hall-like syndrome in a homozygous patient should be taken into account in genetic counseling of families with PAPA1/PAPB.</AbstractText>
          <CopyrightInformation>© 2020 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kariminejad</LastName>
            <ForeName>Ariana</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0002-8467-4728</Identifier>
            <AffiliationInfo>
              <Affiliation>Kariminejad-Najmabadi Pathology &amp; Genetics Center, Tehran, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ghaderi-Sohi</LastName>
            <ForeName>Siavash</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Kariminejad-Najmabadi Pathology &amp; Genetics Center, Tehran, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Keshavarz</LastName>
            <ForeName>Elham</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, Mahdieh Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hashemi</LastName>
            <ForeName>Seyed Abolghasem</ForeName>
            <Initials>SA</Initials>
            <AffiliationInfo>
              <Affiliation>Parsian Hospital, Tehran, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Parsimehr</LastName>
            <ForeName>Elham</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Kariminejad-Najmabadi Pathology &amp; Genetics Center, Tehran, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Szenker-Ravi</LastName>
            <ForeName>Emmanuelle</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Medical Biology, Agency for Science, Technology, and Research, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Khatoo</LastName>
            <ForeName>Muznah</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Medical Biology, Agency for Science, Technology, and Research, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Faraji Zonooz</LastName>
            <ForeName>Mehrshid</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Kariminejad-Najmabadi Pathology &amp; Genetics Center, Tehran, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Reversade</LastName>
            <ForeName>Bruno</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Medical Biology, Agency for Science, Technology, and Research, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Najmabadi</LastName>
            <ForeName>Hossein</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Kariminejad-Najmabadi Pathology &amp; Genetics Center, Tehran, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hennekam</LastName>
            <ForeName>Raoul C</ForeName>
            <Initials>RC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Amsterdam UMC, Amsterdam, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>03</Month>
          <Day>10</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Denmark</Country>
        <MedlineTA>Clin Genet</MedlineTA>
        <NlmUniqueID>0253664</NlmUniqueID>
        <ISSNLinking>0009-9163</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C065683">GLI3 protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000074290">Zinc Finger Protein Gli3</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <SupplMeshList>
        <SupplMeshName Type="Disease" UI="C562429">Polydactyly, Postaxial</SupplMeshName>
      </SupplMeshList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000015" MajorTopicYN="N">Abnormalities, Multiple</DescriptorName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D037881" MajorTopicYN="N">Aborted Fetus</DescriptorName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005385" MajorTopicYN="N">Fingers</DescriptorName>
          <QualifierName UI="Q000002" MajorTopicYN="Y">abnormalities</QualifierName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006579" MajorTopicYN="N">Heterozygote</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006720" MajorTopicYN="N">Homozygote</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009419" MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D054975" MajorTopicYN="N">Pallister-Hall Syndrome</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010375" MajorTopicYN="N">Pedigree</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017689" MajorTopicYN="N">Polydactyly</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014034" MajorTopicYN="N">Toes</DescriptorName>
          <QualifierName UI="Q000002" MajorTopicYN="Y">abnormalities</QualifierName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000074290" MajorTopicYN="N">Zinc Finger Protein Gli3</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">
GLI3</Keyword>
        <Keyword MajorTopicYN="Y">Pallister-Hall syndrome</Keyword>
        <Keyword MajorTopicYN="Y">heterozygote</Keyword>
        <Keyword MajorTopicYN="Y">homozygote</Keyword>
        <Keyword MajorTopicYN="Y">postaxial polydactyly</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>3</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>6</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>3</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32112393</ArticleId>
        <ArticleId IdType="doi">10.1111/cge.13730</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Haycraft JK, Banizs B, Aydin-Son Y, et al. Gli2 and Gli3 localize to cilia and require the intraflagellar transport protein polaris for processing and function. PLoS Genet. 2005;1(4):e53.</Citation>
        </Reference>
        <Reference>
          <Citation>Iafolla K, Fratkin JD, Spiegel PK, Cohen MM, Graham JM. Case report and delineation of the congenital hypothalamic hamartoblastoma syndrome (Pallister-hall syndrome). Am J Med Genet. 1989;33:489-499.</Citation>
        </Reference>
        <Reference>
          <Citation>Pallister PD, Hecht F, Herrman J. Three additional cases of the congenital hypothalamic “hamartoblastoma” (Pallister-hall) syndrome. Am J Med Genet. 1989;33:500-501.</Citation>
        </Reference>
        <Reference>
          <Citation>Umm-e-Kalsoom, Basit S, Kamran-ul-Hassan Naqvi S, et al. Genetic mapping of an autosomal recessive postaxial polydactyly type a to chromosome 13q13.3-q21.2 and screening of the candidate genes. Hum Genet. 2012;131:415-422.</Citation>
        </Reference>
        <Reference>
          <Citation>Kucheria K, Kenue RK, Taneja N. An Indian family with postaxial polydactyly in four generations. Clin Genet. 1981;20:36-39.</Citation>
        </Reference>
        <Reference>
          <Citation>Ventruto V, Theo G, Celona A, et al. A and B postaxial polydactyly in two members of the same family. Clin Genet. 1980;18:342-347.</Citation>
        </Reference>
        <Reference>
          <Citation>Verloes A, David A, Ngo L, Bottani A. Stringent delineation of Pallister-hall syndrome in two long surviving patients: importance of radiological anomalies of the hands. J Med Genet. 1995;32:605-611.</Citation>
        </Reference>
        <Reference>
          <Citation>Johnston JJ, Sapp JC, Turner JT, et al. Molecular analysis expands the spectrum of phenotypes associated with GLI3 mutations. Hum Mutat. 2010;31(10):1142-1154.</Citation>
        </Reference>
        <Reference>
          <Citation>Johnston JJ, Olivos-Glander I, Killoran C, et al. Linkage mapping and phenotypic analysis of autosomal dominant Pallister-hall syndrome. J Med Genet. 1997;34(6):441-446.</Citation>
        </Reference>
        <Reference>
          <Citation>Al-Qattan MM, Shamseldin HE, Salih MA, et al. GLI3-related polydactyly: a review. Clin Genet. 2017;92(5):457-466.</Citation>
        </Reference>
        <Reference>
          <Citation>Cheng B, Dong Y, He L, et al. Crossed polydactyly type I caused by a point mutation in the GLI3 gene in a large Chinese pedigree. J Clin Lab Anal. 2006;20(4):133-138.</Citation>
        </Reference>
        <Reference>
          <Citation>Radhakrishna U, Bornholdt D, Scott HS, et al. The phenotypic spectrum of GLI3 morphopathies includes autosomal dominant preaxial polydactyly type-IV and postaxial polydactyly type-a/B; no phenotype prediction from the position of GLI3 mutations. Am J Hum Genet. 1999;65(3):645-655.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang Z, Wang J, Li Y, et al. Novel frame-shift mutations of GLI3 gene in non-syndromic postaxial polydactyly patients. Clin Chim Acta. 2014;433:195-199.</Citation>
        </Reference>
        <Reference>
          <Citation>Patel R, Singh CB, Bhattachaya V, et al. GLI3 mutations in syndromic and on-syndromic polydactyly in two Indian families. Congenit Anom (Kyoto). 2016;56:94-97.</Citation>
        </Reference>
        <Reference>
          <Citation>Böse J, Grotewold L, Rüther U. Pallister-hall syndrome phenotype in mice mutant for Gli3. Hum Mol Genet. 2002;11(9):1129-1135.</Citation>
        </Reference>
        <Reference>
          <Citation>Al-Hamed MH, Alsahan N, Rice SJ, Edwards N, et al. Biallelic PKD1 mutations underlie early-onset autosomal dominant polycystic kidney disease in Saudi Arabian families. Pediatr Nephrol. 2019;34:1615-1623.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">32112393</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>06</Month>
        <Day>04</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>06</Month>
        <Day>04</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1399-0004</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>97</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Clinical genetics</Title>
          <ISOAbbreviation>Clin Genet</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A GLI3 variant leading to polydactyly in heterozygotes and Pallister-Hall-like syndrome in a homozygote.</ArticleTitle>
        <Pagination>
          <StartPage>915</StartPage>
          <EndPage>919</EndPage>
          <MedlinePgn>915-919</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/cge.13730</ELocationID>
        <Abstract>
          <AbstractText>Variants in transcriptional activator Gli Kruppel Family Member 3 (GLI3) have been reported to be associated with several phenotypes including Greig cephalopolysyndactyly syndrome (MIM #175700), Pallister-Hall syndrome (PHS) (MIM #146510), postaxial polydactyly types A1 (PAPA1) and B (PAPB) (MIM #174200), and preaxial polydactyly type 4 (MIM #174700). All these disorders follow an autosomal dominant pattern of inheritance. Hypothalamic hamartomas (MIM 241800) is associated with somatic variants in GLI3. We report a related couple with parents having PAPA1 and PAPB, who had a fetus with a phenotype most compatible with PHS. Molecular analyses demonstrated homozygosity for a pathogenic GLI3 variant (c.1927C &gt; T; p. Arg643*) in the fetus and heterozygosity in the parents. The genetic analysis in this family demonstrates that heterozygosity and homozygosity for the same GLI3 variant can cause a different phenotype. Furthermore, the occurrence of Pallister-Hall-like syndrome in a homozygous patient should be taken into account in genetic counseling of families with PAPA1/PAPB.</AbstractText>
          <CopyrightInformation>© 2020 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Kariminejad</LastName>
            <ForeName>Ariana</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0002-8467-4728</Identifier>
            <AffiliationInfo>
              <Affiliation>Kariminejad-Najmabadi Pathology &amp; Genetics Center, Tehran, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ghaderi-Sohi</LastName>
            <ForeName>Siavash</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Kariminejad-Najmabadi Pathology &amp; Genetics Center, Tehran, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Keshavarz</LastName>
            <ForeName>Elham</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, Mahdieh Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hashemi</LastName>
            <ForeName>Seyed Abolghasem</ForeName>
            <Initials>SA</Initials>
            <AffiliationInfo>
              <Affiliation>Parsian Hospital, Tehran, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Parsimehr</LastName>
            <ForeName>Elham</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Kariminejad-Najmabadi Pathology &amp; Genetics Center, Tehran, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Szenker-Ravi</LastName>
            <ForeName>Emmanuelle</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Medical Biology, Agency for Science, Technology, and Research, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Khatoo</LastName>
            <ForeName>Muznah</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Medical Biology, Agency for Science, Technology, and Research, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Faraji Zonooz</LastName>
            <ForeName>Mehrshid</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Kariminejad-Najmabadi Pathology &amp; Genetics Center, Tehran, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Reversade</LastName>
            <ForeName>Bruno</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Institute of Medical Biology, Agency for Science, Technology, and Research, Singapore, Singapore.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Najmabadi</LastName>
            <ForeName>Hossein</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Kariminejad-Najmabadi Pathology &amp; Genetics Center, Tehran, Iran.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hennekam</LastName>
            <ForeName>Raoul C</ForeName>
            <Initials>RC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Amsterdam UMC, Amsterdam, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>03</Month>
          <Day>10</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Denmark</Country>
        <MedlineTA>Clin Genet</MedlineTA>
        <NlmUniqueID>0253664</NlmUniqueID>
        <ISSNLinking>0009-9163</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C065683">GLI3 protein, human</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000074290">Zinc Finger Protein Gli3</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <SupplMeshList>
        <SupplMeshName Type="Disease" UI="C562429">Polydactyly, Postaxial</SupplMeshName>
      </SupplMeshList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000015" MajorTopicYN="N">Abnormalities, Multiple</DescriptorName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D037881" MajorTopicYN="N">Aborted Fetus</DescriptorName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005385" MajorTopicYN="N">Fingers</DescriptorName>
          <QualifierName UI="Q000002" MajorTopicYN="Y">abnormalities</QualifierName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006579" MajorTopicYN="N">Heterozygote</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006720" MajorTopicYN="N">Homozygote</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009419" MajorTopicYN="N">Nerve Tissue Proteins</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D054975" MajorTopicYN="N">Pallister-Hall Syndrome</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010375" MajorTopicYN="N">Pedigree</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017689" MajorTopicYN="N">Polydactyly</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014034" MajorTopicYN="N">Toes</DescriptorName>
          <QualifierName UI="Q000002" MajorTopicYN="Y">abnormalities</QualifierName>
          <QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
          <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000074290" MajorTopicYN="N">Zinc Finger Protein Gli3</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">
GLI3</Keyword>
        <Keyword MajorTopicYN="Y">Pallister-Hall syndrome</Keyword>
        <Keyword MajorTopicYN="Y">heterozygote</Keyword>
        <Keyword MajorTopicYN="Y">homozygote</Keyword>
        <Keyword MajorTopicYN="Y">postaxial polydactyly</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>2</Month>
          <Day>24</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>3</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>6</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>3</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32112393</ArticleId>
        <ArticleId IdType="doi">10.1111/cge.13730</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Title>REFERENCES</Title>
        <Reference>
          <Citation>Haycraft JK, Banizs B, Aydin-Son Y, et al. Gli2 and Gli3 localize to cilia and require the intraflagellar transport protein polaris for processing and function. PLoS Genet. 2005;1(4):e53.</Citation>
        </Reference>
        <Reference>
          <Citation>Iafolla K, Fratkin JD, Spiegel PK, Cohen MM, Graham JM. Case report and delineation of the congenital hypothalamic hamartoblastoma syndrome (Pallister-hall syndrome). Am J Med Genet. 1989;33:489-499.</Citation>
        </Reference>
        <Reference>
          <Citation>Pallister PD, Hecht F, Herrman J. Three additional cases of the congenital hypothalamic “hamartoblastoma” (Pallister-hall) syndrome. Am J Med Genet. 1989;33:500-501.</Citation>
        </Reference>
        <Reference>
          <Citation>Umm-e-Kalsoom, Basit S, Kamran-ul-Hassan Naqvi S, et al. Genetic mapping of an autosomal recessive postaxial polydactyly type a to chromosome 13q13.3-q21.2 and screening of the candidate genes. Hum Genet. 2012;131:415-422.</Citation>
        </Reference>
        <Reference>
          <Citation>Kucheria K, Kenue RK, Taneja N. An Indian family with postaxial polydactyly in four generations. Clin Genet. 1981;20:36-39.</Citation>
        </Reference>
        <Reference>
          <Citation>Ventruto V, Theo G, Celona A, et al. A and B postaxial polydactyly in two members of the same family. Clin Genet. 1980;18:342-347.</Citation>
        </Reference>
        <Reference>
          <Citation>Verloes A, David A, Ngo L, Bottani A. Stringent delineation of Pallister-hall syndrome in two long surviving patients: importance of radiological anomalies of the hands. J Med Genet. 1995;32:605-611.</Citation>
        </Reference>
        <Reference>
          <Citation>Johnston JJ, Sapp JC, Turner JT, et al. Molecular analysis expands the spectrum of phenotypes associated with GLI3 mutations. Hum Mutat. 2010;31(10):1142-1154.</Citation>
        </Reference>
        <Reference>
          <Citation>Johnston JJ, Olivos-Glander I, Killoran C, et al. Linkage mapping and phenotypic analysis of autosomal dominant Pallister-hall syndrome. J Med Genet. 1997;34(6):441-446.</Citation>
        </Reference>
        <Reference>
          <Citation>Al-Qattan MM, Shamseldin HE, Salih MA, et al. GLI3-related polydactyly: a review. Clin Genet. 2017;92(5):457-466.</Citation>
        </Reference>
        <Reference>
          <Citation>Cheng B, Dong Y, He L, et al. Crossed polydactyly type I caused by a point mutation in the GLI3 gene in a large Chinese pedigree. J Clin Lab Anal. 2006;20(4):133-138.</Citation>
        </Reference>
        <Reference>
          <Citation>Radhakrishna U, Bornholdt D, Scott HS, et al. The phenotypic spectrum of GLI3 morphopathies includes autosomal dominant preaxial polydactyly type-IV and postaxial polydactyly type-a/B; no phenotype prediction from the position of GLI3 mutations. Am J Hum Genet. 1999;65(3):645-655.</Citation>
        </Reference>
        <Reference>
          <Citation>Wang Z, Wang J, Li Y, et al. Novel frame-shift mutations of GLI3 gene in non-syndromic postaxial polydactyly patients. Clin Chim Acta. 2014;433:195-199.</Citation>
        </Reference>
        <Reference>
          <Citation>Patel R, Singh CB, Bhattachaya V, et al. GLI3 mutations in syndromic and on-syndromic polydactyly in two Indian families. Congenit Anom (Kyoto). 2016;56:94-97.</Citation>
        </Reference>
        <Reference>
          <Citation>Böse J, Grotewold L, Rüther U. Pallister-hall syndrome phenotype in mice mutant for Gli3. Hum Mol Genet. 2002;11(9):1129-1135.</Citation>
        </Reference>
        <Reference>
          <Citation>Al-Hamed MH, Alsahan N, Rice SJ, Edwards N, et al. Biallelic PKD1 mutations underlie early-onset autosomal dominant polycystic kidney disease in Saudi Arabian families. Pediatr Nephrol. 2019;34:1615-1623.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
